Revolutionizing Clinical Research at APAC MedTech Forum 2024!
Sep 11, 2024
AlphaLife Sciences expands its presence by joining BIO HK 2024, showcasing GenAI-powered solutions for clinical research at this leading biotech event.
We're excited to share that AlphaLife Sciences had the privilege of showcasing our breakthrough GenAI-powered medical solutions under Johnson & Johnson Innovations(JLab) at the APAC MedTech Forum 2024!
Our innovative solutions generated significant buzz among industry leaders, highlighting our ability to dramatically accelerate critical processes in clinical research, from CSR writing and protocol writing to patient safety narratives. With our platform, big pharma can trust that GenAI-generated content meets the highest standards of quality and accuracy, unlocking new efficiencies without compromising compliance.
As a proud member of JnJ Innovations(JLab), with backing from the NVIDIA Inception Program and Microsoft for Startups Pegasus Program, we are driving a transformation in how clinical research is conducted, enabling faster, more precise outcomes across the pharmaceutical industry.
A heartfelt thank you to Sharon Chan, Alessandro Falcone, MD and the JnJ Innovations – JLABS Singapore team for this amazing platform. Special recognition also goes to Gabriel SIM and the Asia Pacific Medical Technology Association (APACMed) team for executing such a successful event.
We're excited to continue the conversation with global pharma leaders and collaborate on shaping the future of MedTech and clinical research together.
To learn more about us, follow us on LinkedIn: https://www.linkedin.com/company/alphalife-sciences/
